RxDoctor Payments Data

Jacob Kraemer, MD

Pain Medicine · Madison, WINPI 1730601907

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.8%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 29.6% of the total. Reporting peaked in 2023 at $4,318 and has fallen 59.5% since, to $1,750 in 2025.

$11,397in general payments, 2019–2025

Across 99 payments — averaging $115.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Boston Scientific$3K
  • SPR Therapeutics, Inc$2K
  • Stryker$1K
  • Medtronic$719
  • Foundation Fusion Solutions, LLC$551
  • plus $674 from 6 others

What the payments were for

  • Travel & lodging$5,25346%
  • Food & beverage$6,12954%
  • Entertainment$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,397 in reported general payments places this provider in the 80th percentile of 82 pain medicine providers in Wisconsin.

See all pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$144,429
Medicare patients
241
Services billed
8,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine11$1,955
Tizanidine Hcl14$82
Meloxicam15$51

Paid to pharmacies, not to this prescriber.

Other pain medicine in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →